Cargando…
Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder
BACKGROUND: In Canada, low awareness of evidence-based interventions for the clinical management of alcohol use disorder exists among health care providers and people who could benefit from care. To address this gap, the Canadian Research Initiative in Substance Misuse convened a national committee...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581718/ https://www.ncbi.nlm.nih.gov/pubmed/37844924 http://dx.doi.org/10.1503/cmaj.230715 |
_version_ | 1785122194991349760 |
---|---|
author | Wood, Evan Bright, Jessica Hsu, Katrina Goel, Nirupa Ross, Josey W.G. Hanson, Averill Teed, Rand Poulin, Ginette Denning, Bryany Corace, Kim Chase, Corrina Halpape, Katelyn Lim, Ronald Kealey, Tim Rehm, Jürgen |
author_facet | Wood, Evan Bright, Jessica Hsu, Katrina Goel, Nirupa Ross, Josey W.G. Hanson, Averill Teed, Rand Poulin, Ginette Denning, Bryany Corace, Kim Chase, Corrina Halpape, Katelyn Lim, Ronald Kealey, Tim Rehm, Jürgen |
author_sort | Wood, Evan |
collection | PubMed |
description | BACKGROUND: In Canada, low awareness of evidence-based interventions for the clinical management of alcohol use disorder exists among health care providers and people who could benefit from care. To address this gap, the Canadian Research Initiative in Substance Misuse convened a national committee to develop a guideline for the clinical management of high-risk drinking and alcohol use disorder. METHODS: Development of this guideline followed the ADAPTE process, building upon the 2019 British Columbia provincial guideline for alcohol use disorder. A national guideline committee (consisting of 36 members with diverse expertise, including academics, clinicians, people with lived and living experiences of alcohol use, and people who self-identified as Indigenous or Métis) selected priority topics, reviewed evidence and reached consensus on the recommendations. We used the Appraisal of Guidelines for Research and Evaluation Instrument (AGREE II) and the Guidelines International Network’s Principles for Disclosure of Interests and Management of Conflicts to ensure the guideline met international standards for transparency, high quality and methodological rigour. We rated the final recommendations using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) tool; the recommendations underwent external review by 13 national and international experts and stakeholders. RECOMMENDATIONS: The guideline includes 15 recommendations that cover screening, diagnosis, withdrawal management and ongoing treatment, including psychosocial treatment interventions, pharmacotherapies and community-based programs. The guideline committee identified a need to emphasize both underused interventions that may be beneficial and common prescribing and other practice patterns that are not evidence based and that may potentially worsen alcohol use outcomes. INTERPRETATION: The guideline is intended to be a resource for physicians, policymakers and other clinical and nonclinical personnel, as well as individuals, families and communities affected by alcohol use. The recommendations seek to provide a framework for addressing a large burden of unmet treatment and care needs for alcohol use disorder within Canada in an evidence-based manner. |
format | Online Article Text |
id | pubmed-10581718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | CMA Impact Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105817182023-10-18 Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder Wood, Evan Bright, Jessica Hsu, Katrina Goel, Nirupa Ross, Josey W.G. Hanson, Averill Teed, Rand Poulin, Ginette Denning, Bryany Corace, Kim Chase, Corrina Halpape, Katelyn Lim, Ronald Kealey, Tim Rehm, Jürgen CMAJ Guideline BACKGROUND: In Canada, low awareness of evidence-based interventions for the clinical management of alcohol use disorder exists among health care providers and people who could benefit from care. To address this gap, the Canadian Research Initiative in Substance Misuse convened a national committee to develop a guideline for the clinical management of high-risk drinking and alcohol use disorder. METHODS: Development of this guideline followed the ADAPTE process, building upon the 2019 British Columbia provincial guideline for alcohol use disorder. A national guideline committee (consisting of 36 members with diverse expertise, including academics, clinicians, people with lived and living experiences of alcohol use, and people who self-identified as Indigenous or Métis) selected priority topics, reviewed evidence and reached consensus on the recommendations. We used the Appraisal of Guidelines for Research and Evaluation Instrument (AGREE II) and the Guidelines International Network’s Principles for Disclosure of Interests and Management of Conflicts to ensure the guideline met international standards for transparency, high quality and methodological rigour. We rated the final recommendations using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) tool; the recommendations underwent external review by 13 national and international experts and stakeholders. RECOMMENDATIONS: The guideline includes 15 recommendations that cover screening, diagnosis, withdrawal management and ongoing treatment, including psychosocial treatment interventions, pharmacotherapies and community-based programs. The guideline committee identified a need to emphasize both underused interventions that may be beneficial and common prescribing and other practice patterns that are not evidence based and that may potentially worsen alcohol use outcomes. INTERPRETATION: The guideline is intended to be a resource for physicians, policymakers and other clinical and nonclinical personnel, as well as individuals, families and communities affected by alcohol use. The recommendations seek to provide a framework for addressing a large burden of unmet treatment and care needs for alcohol use disorder within Canada in an evidence-based manner. CMA Impact Inc. 2023-10-16 2023-10-16 /pmc/articles/PMC10581718/ /pubmed/37844924 http://dx.doi.org/10.1503/cmaj.230715 Text en © 2023 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Guideline Wood, Evan Bright, Jessica Hsu, Katrina Goel, Nirupa Ross, Josey W.G. Hanson, Averill Teed, Rand Poulin, Ginette Denning, Bryany Corace, Kim Chase, Corrina Halpape, Katelyn Lim, Ronald Kealey, Tim Rehm, Jürgen Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder |
title | Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder |
title_full | Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder |
title_fullStr | Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder |
title_full_unstemmed | Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder |
title_short | Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder |
title_sort | canadian guideline for the clinical management of high-risk drinking and alcohol use disorder |
topic | Guideline |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581718/ https://www.ncbi.nlm.nih.gov/pubmed/37844924 http://dx.doi.org/10.1503/cmaj.230715 |
work_keys_str_mv | AT woodevan canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT brightjessica canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT hsukatrina canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT goelnirupa canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT rossjoseywg canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT hansonaverill canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT teedrand canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT poulinginette canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT denningbryany canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT coracekim canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT chasecorrina canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT halpapekatelyn canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT limronald canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT kealeytim canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder AT rehmjurgen canadianguidelinefortheclinicalmanagementofhighriskdrinkingandalcoholusedisorder |